Inactive Instrument

News Acro Biomedical Co., Ltd. Other OTC

Equities

ACBM

US0048921052

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	02/23/02	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/23/21	CI
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/22/22	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	13/22/13	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	13/22/13	CI
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/22/16	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
ACRO BIOMEDICAL CO., LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	16/22/16	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	16/22/16	CI
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt	15/22/15	CI
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/21/23	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	23/21/23	CI
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	24/21/24	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	24/21/24	CI
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	25/21/25	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/21/25	CI
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	03/21/03	AQ
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	03/21/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Acro Biomedical Co., Ltd. Other OTC

Equities

ACBM

US0048921052

Summary

Filters